Venlor
$ 66,00 – $ 338,00Price range: $ 66,00 through $ 338,00
Ventolin
$ 47,00 – $ 264,00Price range: $ 47,00 through $ 264,00
Ventodep ER
$ 53,00 – $ 561,00Price range: $ 53,00 through $ 561,00
Ventodep ER is a specialized medication designed to protect the lining of the stomach and duodenum from irritation. It features an extended-release formulation of Misoprostol, which effectively reduces the amount of acid produced by the stomach while increasing protective mucus. This medication is primarily indicated for the prevention of gastric ulcers in patients who take nonsteroidal anti-inflammatory drugs (NSAIDs) on a regular basis. By supporting the natural defense mechanisms of the digestive tract, it helps lower the risk of serious gastrointestinal complications during long-term pain management. Ventodep ER provides a reliable therapeutic solution for maintaining digestive health in individuals sensitive to the effects of chronic anti-inflammatory therapy.
Active substance: Venlafaxine
SKU:
Ventodep ER
Categories: AntiDepressants, Anxiety
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Ventodep ER belongs to the class of medications known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It is a prescription extended-release formulation designed to help regulate neurotransmitter concentrations within the central nervous system. In accordance with U.S. Food and Drug Administration (FDA) regulations, this medication is available only with a valid prescription from a licensed healthcare provider.
Extended-release formulations such as Ventodep ER release active medication gradually over an extended period, allowing for once-daily dosing schedules. Patient compliance, adherence to prescribed administration guidelines, and ongoing clinical oversight are essential components for achieving therapeutic goals while managing potential clinical risks.
| Parameter | Details |
|---|---|
| Drug Name | Ventodep ER |
| Active Ingredient | Venlafaxine (extended-release formulation) |
| Therapeutic Class | Serotonin-norepinephrine reuptake inhibitor (SNRI) |
| Route of Administration | Oral |
| Prescription Status | Prescription (Rx) only |
| Primary Purpose | Management of major depressive disorder and anxiety disorders |
| Storage Conditions | Controlled room temperature (68°F to 77°F / 20°C to 25°C) |
Clinical Overview and Usage Guidelines
What it’s used for
Ventodep ER is primarily indicated for the management and treatment of major depressive disorder (MDD) in adult patients. Extended-release SNRIs in this pharmacological category are also frequently prescribed for generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder with or without agoraphobia. Clinical evaluation by a qualified prescriber determines the exact indication and treatment duration based on individual diagnostic criteria. Any application outside of FDA-approved label indications–such as off-label use for neuropathic pain or vasomotor symptoms–must be carefully evaluated by a medical professional regarding potential risks and clinical efficacy.
How the drug works
The mechanism of action of Ventodep ER involves the potentiation of neurotransmitter activity in the central nervous system. The active component inhibits the neuronal reuptake of two key monoamine neurotransmitters: serotonin (5-HT) and norepinephrine (NE). At higher therapeutic doses, the drug also demonstrates weak inhibition of dopamine reuptake. By blocking reuptake transporters, Ventodep ER increases the concentration of active neurotransmitters in the synaptic cleft. This neurochemical adjustment helps restore emotional balance, alleviate depressive symptoms, and reduce excessive anxiety over time. The extended-release delivery system ensures steady systemic drug concentration across a 24-hour period.
What happens in the body
Following oral ingestion, Ventodep ER is absorbed through the gastrointestinal tract. The extended-release formulation contains specialized spheroids that release the active compound slowly into the digestive system. Peak plasma concentrations of the active substance and its primary active metabolite, O-desmethylvenlafaxine (ODV), are reached several hours post-dose. The drug is extensively metabolized in the liver, primarily via the cytochrome P450 CYP2D6 isoenzyme pathway, with secondary metabolism mediated by CYP3A4. Excretion occurs predominantly through the kidneys as active and inactive metabolites. Patients with renal or hepatic impairment may demonstrate altered clearance kinetics, necessitating individualized dosage modifications by a physician.
Dosing schedule
Ventodep ER must be administered strictly according to the dosing regimen prescribed by a licensed healthcare provider. The standard administration route is oral, taken once daily at approximately the same time each day, either in the morning or evening. Capsules should be swallowed whole with water and taken alongside food to minimize gastrointestinal side effects. Capsules must not be crushed, chewed, divided, or dissolved in liquid, as compromising the extended-release membrane causes rapid drug release, increasing the risk of toxicity. Initial therapeutic doses are typically low and may be titrated upward gradually by a clinician based on individual clinical response and tolerability.
If you skip a dose
If a dose of Ventodep ER is missed, it should be taken as soon as remembered on the same day. However, if the time is close to the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule resumed. Double doses should never be taken to compensate for a missed capsule. Maintaining consistent plasma concentrations is important for therapeutic stability and preventing withdrawal-like symptoms. If multiple doses are missed consecutively, patients should consult their pharmacist or treating physician for specific guidance on re-initiating therapy.
What not to combine
Ventodep ER has significant potential for pharmacodynamic and pharmacokinetic interactions with other substances. Concomitant administration with monoamine oxidase inhibitors (MAOIs) is strictly contraindicated due to the severe risk of serotonin syndrome; a wash-out period of at least 14 days is required when transitioning between these agents. Combining Ventodep ER with other serotonergic medications–such as SSRIs, triptans, tramadol, or St. John’s wort–further elevates the risk of serotonin toxicity. Additionally, concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or oral anticoagulants may impair platelet aggregation and increase the risk of upper gastrointestinal bleeding. Patients must provide a comprehensive list of all current medications to their prescribing clinician.
What to avoid while taking it
Ventodep ER should consistently be administered with food to reduce common early gastrointestinal side effects such as nausea. The consumption of alcoholic beverages should be avoided during treatment. Alcohol can potentiate the central nervous system depressant effects of SNRI medications, leading to exaggerated drowsiness, impaired motor skills, reduced cognitive alertness, and unpredictable mood alterations. Patients should also avoid sudden dietary changes or unverified dietary supplements without prior consultation with a healthcare professional, as certain botanicals can alter hepatic enzyme activity and drug processing.
Adverse reactions
As with all psychoactive prescription medications, Ventodep ER may produce side effects, though individual susceptibility varies. Common adverse reactions observed in clinical trials include nausea, xerostomia (dry mouth), dizziness, somnolence, insomnia, hyperhidrosis (excessive sweating), anorexia, and constipation. Sexual dysfunction–including delayed ejaculation, erectile dysfunction, and decreased libido–is also recognized within this drug class. Dose-dependent increases in blood pressure can occur, requiring baseline and periodic blood pressure monitoring during clinical check-ups. Many mild side effects manifest early in treatment and may diminish as physiological adaptation occurs over several weeks.
Red flags
Immediate emergency medical evaluation is necessary if severe adverse events develop. Red flag symptoms requiring emergency intervention include:
- Signs of serotonin syndrome: high fever, severe agitation, confusion, muscle rigidity, hyperreflexia, rapid heart rate, and diaphoresis.
- Severe hypersensitivity reactions: facial, lip, tongue, or throat swelling, difficulty breathing, or severe cutaneous skin eruptions.
- Unusual or excessive bleeding, easy bruising, or black tarry stools.
- Ocular changes: sudden eye pain, swelling, visual disturbances, or seeing halos around lights (indicative of acute angle-closure glaucoma).
- Cardiovascular symptoms: severe hypertension, chest tightness, or irregular heart rhythms.
Important precautions
Ventodep ER carries prominent warnings regarding the risk of suicidal thoughts and behaviors in children, adolescents, and young adults during initial treatment stages or dose adjustments. Prescribers must monitor patients closely for behavioral changes, worsening depression, or sudden agitation. Abrupt cessation of Ventodep ER can precipitate discontinuation syndrome, characterized by dizziness, sensory disturbances (such as electric shock sensations), headaches, anxiety, and nausea. Tapering the dosage gradually under medical supervision is mandatory when discontinuing therapy. In pregnant or nursing individuals, the drug should be used only if the potential benefit justifies potential fetal or neonatal risks. Elderly patients should be monitored for hyponatremia related to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Storage and expiration
Ventodep ER capsules should be stored at controlled room temperature, ideally between 68°F to 77°F (20°C to 25°C), with temporary excursions permitted between 59°F and 86°F (15°C to 30°C). Keep the container tightly closed, away from excessive heat, direct sunlight, and ambient moisture. Store out of reach of children and domestic animals. Do not use Ventodep ER after the expiration date clearly marked on the original container packaging. Expired or unneeded medications should be disposed of via local authorized pharmacy take-back programs or in accordance with federal prescription waste guidelines.
Common Questions
How long does it take for Ventodep ER to show therapeutic results?
Therapeutic response to Ventodep ER is typically gradual rather than immediate. While subtle improvements in physical symptoms such as sleep patterns or energy levels may be observed within 1 to 2 weeks, noticeable reductions in depressive or anxiety symptoms often require 4 to 8 weeks of consistent daily administration. Patients should maintain their prescribed schedule even if initial therapeutic changes are not immediately apparent.
Is it safe to drive or operate machinery while taking Ventodep ER?
Ventodep ER can influence central nervous system activity, causing side effects such as dizziness, somnolence, or altered visual acuity. Patients should avoid operating motor vehicles, handling hazardous machinery, or participating in tasks requiring full mental alertness until they have adequately determined how the medication impacts their individual physical and cognitive performance.
What should I do if I experience dry mouth or nausea when starting Ventodep ER?
Nausea and dry mouth are common transient reactions during the initial weeks of treatment. Taking the dose with meals can significantly diminish gastrointestinal upset. For dry mouth relief, maintaining proper hydration, utilizing sugar-free gum, or using oral lubricants can help alleviate symptoms. If gastrointestinal symptoms persist or interfere with nutritional intake, contact your prescribing physician.
Can Ventodep ER be stopped abruptly if I feel completely better?
No, Ventodep ER should never be stopped abruptly without clinical oversight. Abrupt discontinuation frequently leads to withdrawal-like symptoms known as discontinuation syndrome, which includes dizziness, headache, sensory paresthesias, nausea, and emotional irritability. Any dose reduction or treatment termination must follow a gradual tapering schedule supervised by a healthcare provider.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
150mg |
|---|---|
| Package |
20 pills ,30 pills ,40 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills |
| Ενεργός Ουσία |
Related products
Abilify
$ 45,00 – $ 413,00Price range: $ 45,00 through $ 413,00
Active substance: Aripiprazole
More Details
This product has multiple variants. The options may be chosen on the product page
Atarax
$ 42,00 – $ 150,00Price range: $ 42,00 through $ 150,00
Active substance: Hydroxyzine
More Details
This product has multiple variants. The options may be chosen on the product page
Clozaril
$ 45,00 – $ 129,00Price range: $ 45,00 through $ 129,00
Active substance: Clozapine
More Details
This product has multiple variants. The options may be chosen on the product page
Duzela
$ 36,00 – $ 83,00Price range: $ 36,00 through $ 83,00
Active substance: Duloxetine
More Details
This product has multiple variants. The options may be chosen on the product page
Emsam
$ 66,00 – $ 345,00Price range: $ 66,00 through $ 345,00
Active substance: Selegiline
More Details
This product has multiple variants. The options may be chosen on the product page
Phenergan
$ 42,00 – $ 136,00Price range: $ 42,00 through $ 136,00
Active substance: Promethazine
More Details
This product has multiple variants. The options may be chosen on the product page
Serpina
$ 41,00 – $ 246,00Price range: $ 41,00 through $ 246,00
Active substance: Sarpagandha
More Details
This product has multiple variants. The options may be chosen on the product page
Tofranil
$ 40,00 – $ 292,00Price range: $ 40,00 through $ 292,00
Active substance: Imipramine
More Details
This product has multiple variants. The options may be chosen on the product page
